Ind-Swift Laboratories Limited (INDSWFTLAB.NS)
INR 105.01
(-1.58%)
INR 105.01
(-1.58%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 12.8 Billion | 12.07 Billion | 10.38 Billion | 8.91 Billion | 7.79 Billion | 7.56 Billion |
| Cost of Revenue | 8.67 Billion | 6.55 Billion | 6.1 Billion | 5.3 Billion | 4.73 Billion | 4.67 Billion |
| Gross Profit | 4.13 Billion | 5.51 Billion | 4.28 Billion | 3.61 Billion | 3.06 Billion | 2.88 Billion |
| Operating Expenses | 2.12 Billion | 3.79 Billion | 3.35 Billion | 2.5 Billion | 2.33 Billion | 2.34 Billion |
| Selling, General and Administrative Expenses | 2.12 Billion | 635.76 Million | 633.62 Million | 493.74 Million | 421.9 Million | 423 Million |
| Research and Development Expenses | - | 425.73 Million | 327.16 Million | 66.9 Million | 3.93 Million | 5.33 Million |
| Other Expenses | - | 335 Million | 139.96 Million | 34.8 Million | -5.96 Million | 29.12 Million |
| Cost and Expenses | 10.79 Billion | 10.35 Billion | 9.46 Billion | 7.8 Billion | 7.06 Billion | 7.02 Billion |
| Operating Income | 2 Billion | 1.81 Billion | 924.22 Million | 1.1 Billion | 739.59 Million | 444.89 Million |
| Interest Expense | 511.03 Million | 921.66 Million | 914.52 Million | 933.53 Million | 1.02 Billion | 839.59 Million |
| Income Tax Expense | 1.6 Billion | 386.85 Million | 146.81 Million | 211.55 Million | 14.17 Million | 207.3 Million |
| Earnings before Tax | 5.81 Billion | 865.21 Million | 125.32 Million | 180.08 Million | -197.71 Million | 591.71 Million |
| Net Income | 4.2 Billion | 475.96 Million | -21.49 Million | -31.47 Million | -211.88 Million | 384.4 Million |
| Earnings Per Share Basic | 71.24 | 8.06 | -0.36 | -0.53 | -4.28 | 7.04 |
| Earnings Per Share Diluted | 71.24 | 8.06 | -0.36 | -0.53 | -4.28 | 7.04 |
| Weighted Average Shares Outstanding | 59.09 Million | 59.08 Million | 59.08 Million | 59.08 Million | 49.46 Million | 54.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.09 Million | 59.08 Million | 59.08 Million | 59.08 Million | 49.46 Million | 54.63 Million |
| Gross Margin | 0.32 | 0.46 | 0.41 | 0.41 | 0.39 | 0.38 |
| EBIT Margin | 0.54 | 0.22 | 0.24 | 0.22 | 0.22 | 0.22 |
| Profit Margin | 0.33 | 0.04 | -0.00 | -0.00 | -0.03 | 0.05 |
| EBITDA | 6.86 Billion | 2.35 Billion | 2.39 Billion | 2.05 Billion | 1.77 Billion | 2.45 Billion |
| Earnings Before Tax Margin | 0.16 | 0.15 | 0.09 | 0.12 | 0.09 | 0.06 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 331.66 Million | 3.93 Billion | 12.8 Billion | 2.87 Billion | 2.89 Billion | 3.1 Billion |
| Cost of Revenue | 336.48 Million | 3.65 Billion | 8.67 Billion | 1.55 Billion | 1.44 Billion | 1.62 Billion |
| Gross Profit | -4.81 Million | 282.74 Million | 4.13 Billion | 1.32 Billion | 1.45 Billion | 1.48 Billion |
| Operating Expenses | 95.09 Million | 782.48 Million | 2.12 Billion | 939.44 Million | 927.52 Million | 1.01 Billion |
| Selling, General and Administrative Expenses | 95.09 Million | 782.48 Million | - | 433.07 Million | 421.05 Million | 390.19 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 111.39 Million | 252.5 Million | 453.67 Million | 71.13 Million | 73.97 Million | 56.05 Million |
| Cost and Expenses | 431.57 Million | 4.43 Billion | 10.79 Billion | 2.49 Billion | 2.37 Billion | 2.63 Billion |
| Operating Income | -99.9 Million | -499.74 Million | 2 Billion | 452.48 Million | 599.04 Million | 464.14 Million |
| Interest Expense | 1.68 Million | -114.72 Million | 511.03 Million | 210.54 Million | 211.37 Million | 203.84 Million |
| Income Tax Expense | -288 Thousand | 1.34 Billion | 1.6 Billion | 46.65 Million | 69.34 Million | 142.39 Million |
| Earnings before Tax | 9.79 Million | 3.73 Billion | 5.81 Billion | 241.94 Million | 387.66 Million | 316.35 Million |
| Net Income | 9.35 Million | 2.38 Billion | 4.2 Billion | 194.18 Million | 316.56 Million | 172.42 Million |
| Earnings Per Share Basic | 0.16 | 40.42 | - | 3.29 | 5.36 | 2.92 |
| Earnings Per Share Diluted | 0.16 | 40.42 | - | 3.29 | 5.36 | 2.92 |
| Weighted Average Shares Outstanding | 59.08 Million | 59.08 Million | 59.08 Million | 59.08 Million | 59.08 Million | 59.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.08 Million | 59.08 Million | 59.08 Million | 59.08 Million | 59.08 Million | 59.08 Million |
| Gross Margin | -0.01 | 0.07 | 0.32 | 0.46 | 0.50 | 0.48 |
| EBIT Margin | -0.29 | -0.09 | - | 0.20 | 0.25 | 0.21 |
| Profit Margin | 0.03 | 0.61 | 0.33 | 0.07 | 0.11 | 0.06 |
| EBITDA | -97.4 Million | -373 Million | - | 588.04 Million | 730.92 Million | 659.05 Million |
| Earnings Before Tax Margin | -0.30 | -0.13 | 0.16 | 0.16 | 0.21 | 0.15 |
PAZA
CARE
0026
CSSPF
SNEGF
RIPLEY